- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| GLUCOTRACK Aktie jetzt für 0€ handeln | |||||
| 30.03. | GlucoTrack, Inc.: Glucotrack Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights | 243 | GlobeNewswire (Europe) | Company prepares to file Investigational Device Exemption (IDE) for Novel CBGM Technology, targeting US Clinical Trial Launch in Second Half of 2026 US Patent and Trademark Office (USPTO) issued patents... ► Artikel lesen | |
| 30.03. | Glucotrack GAAP EPS of -$31.22 | 1 | Seeking Alpha | ||
| 30.03. | Glucotrack, Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 27.03. | GlucoTrack Shares Surge 34% On FDA Submission Progress For Implantable Glucose Monitor | 1 | RTTNews | ||
| 27.03. | GlucoTrack Stock Gains As Data Backs FDA Filing Plans For Glucose Monitoring Tech | 1 | Benzinga.com | ||
| 27.03. | Glucotrack to submit continuous blood glucose monitor for FDA IDE in early Q2 | 1 | MassDevice | ||
| 27.03. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 27.03. | Glucotrack plant FDA-Antrag für implantierbaren Blutzuckersensor | 1 | Investing.com Deutsch | ||
| 27.03. | Glucotrack plans FDA submission for implantable glucose monitor | 1 | Investing.com | ||
| 27.03. | Glucotrack, Inc.: Glucotrack to File Significant IDE with FDA for US Clinical Trial in Early Q2 Based on Critical 2025 Milestones | 746 | GlobeNewswire (Europe) | RUTHERFORD, N.J., March 27, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc. (Nasdaq: GCTK) ("Glucotrack" or the "Company"), a medical technology company focused on the design, development, and commercialization... ► Artikel lesen | |
| 13.03. | Glucotrack, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 10.03. | Glucotrack, Inc.: Glucotrack to Present at LSI USA '26 Medtech Innovation Summit | 1 | GlobeNewswire (USA) | ||
| 29.01. | GlucoTrack Shares Slide 25% Despite New Patent Awards | - | RTTNews | ||
| 29.01. | Glucotrack picks up new patents for continuous blood glucose monitor | 1 | MassDevice | ||
| 29.01. | Glucotrack Stumbles Despite Winning Patent | - | Baystreet.ca | ||
| 29.01. | Glucotrack, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 29.01. | Glucotrack, Inc.: Glucotrack Announces USPTO Approval for Issuance of Patents for Proprietary CBGM Platform | 213 | GlobeNewswire (Europe) | RUTHERFORD, N.J., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Glucotrack, Inc.("Glucotrack", or the "Company") (Nasdaq: GCTK), a medical device company focused on the design, development, and commercialization... ► Artikel lesen | |
| 30.12.25 | Glucotrack, Inc. Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Institutional Investor | 1 | GlobeNewswire (USA) | ||
| 29.12.25 | Glucotrack, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 13.11.25 | Glucotrack GAAP EPS of -$4.64 | 1 | Seeking Alpha |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 14,615 | +2,49 % | BRANDMELDUNG bei Eckert&Ziegler: 2,5% Plus und das könnte erst der Anfang sein - Was das für Ihr Depot bedeutet | ||
| SERNOVA BIOTHERAPEUTICS | 0,094 | -6,73 % | Sernova Biotherapeutics: Sernova Biotherapeutics Announces Close of Non-Brokered Private Placement Financing | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - March 24, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC Pink: SEOVF) (FSE: PSH0) ("Sernova" or the "Company"), a leading regenerative... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB: Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden | EQS-News: SYNLAB
/ Schlagwort(e): Sonstiges
Die Region Stockholm beauftragt SYNLAB mit dem Ausbau ihrer medizinischen Diagnostikdienstleistungen in Schweden
31.03.2026... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,011 | +1,82 % | NuGen Medical Devices Inc.: NuGen Files Patent for Ready-to-Fill COP/COC Needle-Free Injection Nozzle, Advancing Prefilled Nozzle Technology | Toronto, Ontario--(Newsfile Corp. - March 25, 2026) - NuGen Medical Devices Inc. (TSXV: NGMD) ("NuGen"), a leader in needle-free drug delivery, today announced the filing of a new patent covering... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update | -- Increased Net Sales 10% While Lowering Operating Expenses 42% vs. Prior Year Quarter --
-- Delivered $1.0 Million of Operating Income in Q3 2025 --
SAN DIEGO... ► Artikel lesen | |
| UNIDOC HEALTH | 0,056 | -3,44 % | UniDoc stellt Installation des H3 Health Cube in Italien fertig | - Der KI-gestützte Health Cube steht
ab sofort den Patienten im Dorf Guardia Perticara in der italienischen Region Basilikata zur Verfügung.
VANCOUVER, British Columbia... ► Artikel lesen | |
| SONOMA PHARMACEUTICALS | 2,350 | -100,00 % | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces U.S. Retail Launch of Advanced Burn Relief Hydrogel in CVS and Walmart | BOULDER, CO / ACCESS Newswire / March 24, 2026 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader in hypochlorous acid (HOCl) technology, today announced the U.S. retail launch... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,430 | +0,35 % | Co-Diagnostics anticipates India TB test commercialization by Q3 '26 while exploring CoSara SPAC options | ||
| QUIDELORTHO | 13,955 | +8,35 % | QuidelOrtho Corporation: Nathaniel Sisitsky Joins QuidelOrtho as Chief Legal Officer | SAN DIEGO, March 24, 2026 /PRNewswire/ -- QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global leader of in vitro diagnostics, is pleased to announce the appointment... ► Artikel lesen | |
| QUEST DIAGNOSTICS | 168,60 | -0,38 % | Dividendenbekanntmachungen (06.04.2026) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ATRENEW INC ADR US00138L1089 0,1 USD 0,0868 EUR COMMERCIAL METALS COMPANY US2017231034 0,2 USD 0,1736 EUR ESCALADE INC US2960561049 0... ► Artikel lesen | |
| VERU | 2,540 | +1,60 % | Veru Inc.: Veru Enrolls First Patient in Phase 2b PLATEAU Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss | -- The Phase 2b study to assess enobosarm's ability to preserve lean mass, physical function, and bone as well as burn more fat to produce greater quality and quantity of weight loss in older patients... ► Artikel lesen | |
| LIFEWARD | 6,300 | 0,00 % | Lifeward Ltd.: Lifeward Successfully Closes on Strategic Partnership with Oramed | HUDSON, Mass. and YOKNEAM ILLIT, Israel, March 25, 2026 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) ("Lifeward" or the "Company"), a global leader in innovative medical technology to transform... ► Artikel lesen | |
| SENSEONICS | 5,950 | +1,71 % | A look at the tech behind the world's first year-long CGM with Senseonics | ||
| TEMPEST THERAPEUTICS | 1,590 | +1,92 % | Tempest Therapeutics: Tempest Reports Year End 2025 Financial Results and Provides Business Update | Completed strategic acquisition of dual-targeting CAR-T assets from Factor Bioscience Inc. Named Matt Angel, Ph.D., Chief Executive Officer & President Announced positive interim data from the ongoing... ► Artikel lesen | |
| RADNET | 46,600 | -1,06 % | RadNet, Inc.: RadNet Reports Fourth Quarter 2025 Results, Including Record Revenue and Adjusted EBITDA?? and Releases 2026 Financial Guidance | Total Company Revenue increased 14.8% to a quarterly record of $547.7 million in the fourth quarter of 2025 from $477.1 million in the fourth quarter of 2024; Revenue from the Digital Health reportable... ► Artikel lesen |
Das Unternehmen GLUCOTRACK INC kann der Branche Gesundheitswesen zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 0,686 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu GLUCOTRACK INC finden Sie auf Wallstreet Online.